Solid Biosciences to Participate at Upcoming Investor Conferences

Rhea-AI Summary

Solid Biosciences Inc. (SLDB) will be participating in the Leerink Partners Global Biopharma Conference and Barclays 26th Annual Global Healthcare Conference in Miami, FL. Bo Cumbo, the President and CEO, will present on March 13, 2024, at 1:35 pm ET. Institutional investors can arrange meetings with management through Leerink or Barclays representatives.

CHARLESTOWN, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:

• Leerink Partners Global Biopharma Conference – Miami, FL
  1x1 meetings on March 11, 2024
• Barclays 26^th Annual Global Healthcare Conference – Miami, FL
  Bo Cumbo, Solid’s President and Chief Executive Officer, will present on Wednesday, March 13, 2024, at 1:35 pm ET.

A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. A webcast replay will be archived for 30 days on the Events page.

Institutional investors interested in meeting with management during the conference may reach out to their Leerink or Barclays representatives.

About Solid Biosciences
Solid Biosciences is a life sciences company focused on advancing a portfolio of gene therapy candidates and neuromuscular and cardiac programs, including SGT-003, for the treatment of Duchenne muscular dystrophy (Duchenne), SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT), AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, AVB-202-TT for the treatment of Friedreich’s ataxia, and additional assets for the treatment of fatal cardiac diseases. Solid is advancing its diverse pipeline across rare neuromuscular and cardiac diseases, bringing together experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted, Solid’s mandate is to improve the daily lives of patients living with these devastating diseases. For more information, please visit www.solidbio.com.

Solid Biosciences Contact:
Leah Monteiro
VP, Investor Relations & Communications
617-766-3430
lmonteiro@solidbio.com

FAQ

When will Solid Biosciences Inc. (SLDB) participate in the Leerink Partners Global Biopharma Conference?

Solid Biosciences Inc. (SLDB) will participate in the Leerink Partners Global Biopharma Conference on March 11, 2024, in Miami, FL.

Who will present at the Barclays 26th Annual Global Healthcare Conference for Solid Biosciences Inc. (SLDB)?

Bo Cumbo, the President and CEO of Solid Biosciences Inc. (SLDB), will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL.

How can investors watch the live webcast of the presentation by Bo Cumbo for Solid Biosciences Inc. (SLDB)?

Investors can watch the live webcast of the presentation by Bo Cumbo for Solid Biosciences Inc. (SLDB) on the Events page of the Investors section of the Company website.

For how long will the webcast replay be available for the presentation by Bo Cumbo for Solid Biosciences Inc. (SLDB)?

The webcast replay for the presentation by Bo Cumbo for Solid Biosciences Inc. (SLDB) will be archived for 30 days on the Events page of the Company website.

How can institutional investors arrange meetings with management during the conferences for Solid Biosciences Inc. (SLDB)?

Institutional investors interested in meeting with management during the conferences can reach out to their Leerink or Barclays representatives.